PL2677029T3 - Sposoby wytwarzania poddanych obróbce proteolitycznej polipeptydów - Google Patents
Sposoby wytwarzania poddanych obróbce proteolitycznej polipeptydówInfo
- Publication number
- PL2677029T3 PL2677029T3 PL13184864T PL13184864T PL2677029T3 PL 2677029 T3 PL2677029 T3 PL 2677029T3 PL 13184864 T PL13184864 T PL 13184864T PL 13184864 T PL13184864 T PL 13184864T PL 2677029 T3 PL2677029 T3 PL 2677029T3
- Authority
- PL
- Poland
- Prior art keywords
- manufacture
- methods
- proteolytically processed
- processed polypeptides
- polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13184864.0A EP2677029B1 (en) | 2011-05-19 | 2011-05-19 | Methods for the manufacture of proteolytically processed polypeptides |
| EP11004152.2A EP2524963B1 (en) | 2011-05-19 | 2011-05-19 | Methods for the manufacture of proteolytically processed polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2677029T3 true PL2677029T3 (pl) | 2017-10-31 |
Family
ID=44453883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13184864T PL2677029T3 (pl) | 2011-05-19 | 2011-05-19 | Sposoby wytwarzania poddanych obróbce proteolitycznej polipeptydów |
Country Status (6)
| Country | Link |
|---|---|
| EP (4) | EP2524963B1 (pl) |
| DK (1) | DK2677029T3 (pl) |
| ES (3) | ES2974687T3 (pl) |
| HU (1) | HUE033172T2 (pl) |
| PL (1) | PL2677029T3 (pl) |
| PT (1) | PT2677029T (pl) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2677029T3 (pl) | 2011-05-19 | 2017-10-31 | Ipsen Bioinnovation Ltd | Sposoby wytwarzania poddanych obróbce proteolitycznej polipeptydów |
| UA111795C2 (uk) | 2012-11-21 | 2016-06-10 | Сінтаксін Лімітед | Спосіб виробництва поліпептиду, підданого протеолітичному процесингу |
| GB201407525D0 (en) * | 2014-04-29 | 2014-06-11 | Syntaxin Ltd | Manufacture of recombinant clostridium botulinum neurotoxins |
| CA3024331A1 (en) | 2016-05-16 | 2017-11-23 | President And Fellows Of Harvard College | Method for purification and activation of botulinum neurotoxin |
| EP3263710A1 (en) | 2016-07-01 | 2018-01-03 | Ipsen Biopharm Limited | Production of activated clostridial neurotoxins |
| KR102174197B1 (ko) | 2019-06-12 | 2020-11-04 | 주식회사 앤씨비아이티 | 생산성이 향상된 비독성 프로테아제 |
| CA3166885A1 (en) | 2020-03-16 | 2021-09-23 | Nicolae GRIGORE | Treatment of limb spasticity |
| GB202003813D0 (en) | 2020-03-16 | 2020-04-29 | Ipsen Biopharm Ltd | Treatment of upper facial lines |
| KR20240067070A (ko) | 2021-09-16 | 2024-05-16 | 입센 바이오팜 리미티드 | 경부 이상긴장증의 치료에 사용하기 위한 변형된 bont/a |
| GB202113602D0 (en) | 2021-09-23 | 2021-11-10 | Ipsen Biopharm Ltd | Treatment of a disorder affecting an eyelid muscle of a subject |
| JP2024534541A (ja) | 2021-09-23 | 2024-09-20 | イプセン バイオファーム リミテッド | 被験体の眼瞼筋を冒す障害の治療における使用のための改変BoNT/A |
| JP2024540579A (ja) | 2021-11-22 | 2024-10-31 | イプセン バイオファーム リミテッド | 疼痛の治療 |
| GB202206353D0 (en) | 2022-04-29 | 2022-06-15 | Ipsen Biopharm Ltd | Treatment of cervical dystonia |
| GB202206348D0 (en) | 2022-04-29 | 2022-06-15 | Ipsen Biopharm Ltd | Treatment of limb spasticity |
| GB202206361D0 (en) | 2022-04-29 | 2022-06-15 | Ipsen Biopharm Ltd | Treatment of a facial dystonia |
| GB202206362D0 (en) | 2022-04-29 | 2022-06-15 | Ipsen Biopharm Ltd | Treatment of upper facial lines |
| GB202213479D0 (en) | 2022-09-14 | 2022-10-26 | Ipsen Biopharm Ltd | Cell-free clostridial neurotoxin assays |
| GB202307439D0 (en) | 2023-05-18 | 2023-07-05 | Ipsen Biopharm Ltd | Treatment of a headache disorder with botylinum neurotoxin a |
| WO2025093844A1 (en) | 2023-11-01 | 2025-05-08 | Ipsen Biopharm Limited | Use of chimeric botulinum toxin a for treating blepharospasm and hemifacial spasm |
| WO2025093845A1 (en) | 2023-11-01 | 2025-05-08 | Ipsen Biopharm Limited | Use of high dose chimeric botulinum toxin a for the treatment of upper facial lines |
| GB202320108D0 (en) | 2023-12-28 | 2024-02-14 | Ipsen Biopharm Ltd | Biosensor |
| GB202404021D0 (en) | 2024-03-20 | 2024-05-01 | Ipsen Biopharm Ltd | Cell-based neurotoxin assay |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2907695A (en) | 1994-08-08 | 1996-03-07 | Wisconsin Alumni Research Foundation | Purification and pharmaceutical compositions containing type g botulinum neurotoxin |
| US8012491B2 (en) * | 1996-08-23 | 2011-09-06 | Syntaxin, Ltd. | Recombinant toxin fragments |
| DE19856897A1 (de) | 1998-12-10 | 2000-06-15 | Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh | Therapeutikum zur Unterdrückung von Schnarchgeräuschen |
| US7402556B2 (en) * | 2000-08-24 | 2008-07-22 | Medarex, Inc. | Prodrugs activated by plasmin and their use in cancer chemotherapy |
| US9072735B2 (en) * | 2005-10-03 | 2015-07-07 | Yong Qian | Proteinases destroy cancer tumor's solid structure and kill cancer cells locally |
| EP2178905B1 (en) | 2007-07-26 | 2013-11-06 | Allergan, Inc. | Methods of activiting clostridial toxins |
| PL2677029T3 (pl) | 2011-05-19 | 2017-10-31 | Ipsen Bioinnovation Ltd | Sposoby wytwarzania poddanych obróbce proteolitycznej polipeptydów |
-
2011
- 2011-05-19 PL PL13184864T patent/PL2677029T3/pl unknown
- 2011-05-19 ES ES16193811T patent/ES2974687T3/es active Active
- 2011-05-19 EP EP11004152.2A patent/EP2524963B1/en active Active
- 2011-05-19 EP EP24150371.3A patent/EP4375371A3/en active Pending
- 2011-05-19 EP EP13184864.0A patent/EP2677029B1/en not_active Revoked
- 2011-05-19 ES ES11004152T patent/ES2708661T3/es active Active
- 2011-05-19 ES ES13184864.0T patent/ES2634261T3/es active Active
- 2011-05-19 PT PT131848640T patent/PT2677029T/pt unknown
- 2011-05-19 EP EP16193811.3A patent/EP3162894B1/en active Active
- 2011-05-19 DK DK13184864.0T patent/DK2677029T3/da active
- 2011-05-19 HU HUE13184864A patent/HUE033172T2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2677029T (pt) | 2017-08-11 |
| EP2524963A1 (en) | 2012-11-21 |
| EP3162894B1 (en) | 2024-01-10 |
| ES2708661T3 (es) | 2019-04-10 |
| EP3162894A3 (en) | 2017-08-09 |
| EP2677029A3 (en) | 2014-06-11 |
| DK2677029T3 (da) | 2017-08-07 |
| EP4375371A2 (en) | 2024-05-29 |
| EP4375371A3 (en) | 2024-07-31 |
| EP2677029A2 (en) | 2013-12-25 |
| HUE033172T2 (en) | 2017-11-28 |
| ES2634261T3 (es) | 2017-09-27 |
| EP2677029B1 (en) | 2017-05-10 |
| ES2974687T3 (es) | 2024-07-01 |
| EP2524963B1 (en) | 2018-10-31 |
| EP3162894A2 (en) | 2017-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2677029T (pt) | Métodos para o fabrico de polipéptidos processados proteoliticamente | |
| PT2744768T (pt) | Processo para a produção de clínquer de ternesite | |
| IL222454B (en) | A process for the production of recombinant polypeptides | |
| SG11201401282PA (en) | Process for the production of estetrol | |
| EP2552874A4 (en) | PROCESS FOR PREPARING HEXAFLUOR-2 BUTENE | |
| ZA201305972B (en) | Method for the preparation of biphephos | |
| EP2558432A4 (en) | METHOD FOR THE PRODUCTION OF TETRAFLUOROLEFINES | |
| SG10201703051WA (en) | Compounds and methods for the production of suckerin and uses thereof | |
| IL222453B (en) | A process for the production of recombinant polypeptides | |
| SI2784056T1 (sl) | Postopek za selektivno produkcijo n-metil-para anizidina | |
| LT2696959T (lt) | Aplinkai nekenksmingas cemento gamybos būdas | |
| SG11201400939YA (en) | Process for the preparation of methoxymelonal | |
| IL236668A0 (en) | Production method of solid surfaces for construction | |
| SG11201400405TA (en) | Caninised antibodies and method for the production of same | |
| PL2625262T3 (pl) | Sposób wytwarzania białka | |
| SG10201602874VA (en) | Protein production method | |
| HUE044066T2 (hu) | Eljárás metilén-difenil-diizocianát elõállítására | |
| HUP1200171A1 (hu) | Módszerek polipeptidek elõállítására | |
| EP2737065A4 (en) | PROCESS FOR PRODUCING PROTEINS | |
| IL230159A0 (en) | Method for the production of 2-amino-5-cyano-n,3-dimethylbenzamide | |
| ZA201303361B (en) | Process for extrusing particles | |
| PL2522410T3 (pl) | Proces regeneracji proszków gaśniczych | |
| LT2912100T (lt) | Medienos medžiagų gamybos būdas | |
| GB201101794D0 (en) | Protein production | |
| IL229427A0 (en) | Process for preparing protease inhibitors |